EAST WINDSOR, NJ -- (MARKET WIRE) -- December 21, 2006 -- NexMed, Inc. (NASDAQ: NEXM), a developer of innovative transdermal treatments based on its proprietary NexACT® drug delivery technology, announced today it has raised $8.65 million from a private placement of its securities to Southpoint Capital Advisors and RA Capital Management.
